Sfoglia per AUTORE
CARNEVALE A
Collezione ASL Asti

  

Items : 16

Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE) in Journal of Headache and Pain

2025
ASL Asti

Barbanti P; Fiorentini G; Camarda C; Autunno M; Pistoia F; Aurilia C; d’Onofrio F; Egeo G; Carnevale A; Caproni S; Doretti A; Cherchi A; De Simone R; Zucco M; Rinalduzzi S; Colombo B; Filippi M; Quintana S; Russo M; Coppola A; Grugno R; Bartolini M; Viticchi G; Rao R; Albanese M; Vernieri F; Grazzi L; Robotti M; Di Summa A; et alii...

Correction to: Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study. in Neurology and therapy / Neurol Ther. 2024 Oct;13(5):1505-1506. doi: 10.1007/s40120-024-00648-z.

2024
ASL Asti

Barbanti P; Egeo G; Proietti S; d'Onofrio F; Aurilia C; Finocchi C; Di Clemente L; Zucco M; Doretti A; Messina S; Autunno M; Ranieri A; Carnevale A; Colombo B; Filippi M; Tasillo M; Rinalduzzi S; Querzani P; Sette G; Forino L; Zoroddu F; Robotti M; Valenza A; Camarda C; Borrello L; Aguggia M; Viticchi G; Tomino C; Fiorentini G; et alii...

Ultra-late response (>?24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study. in Journal of neurology / J Neurol. 2024 May;271(5):2434-2443. doi: 10.1007/s00415-023-12103-4. Epub 2024 Jan 17.

2024
ASL Asti

Barbanti P; Aurilia C; Egeo G; Proietti S; D'Onofrio F; Torelli P; Aguggia M; Bertuzzo D; Finocchi C; Trimboli M; Cevoli S; Fiorentini G; Orlando B; Zucco M; Di Clemente L; Cetta I; Colombo B; di Poggio MLB; Favoni V; Grazzi L; Salerno A; Carnevale A; Robotti M; Frediani F; Altamura C; Filippi M; Vernieri F; Bonassi S;

Correction to: Ultra-late response (>?24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study. in Journal of neurology / J Neurol. 2024 May;271(5):2444-2445. doi: 10.1007/s00415-024-12287-3.

2024
ASL Asti

Barbanti P; Aurilia C; Egeo G; Proietti S; D'Onofrio F; Torelli P; Aguggia M; Bertuzzo D; Finocchi C; Trimboli M; Cevoli S; Fiorentini G; Orlando B; Zucco M; Di Clemente L; Cetta I; Colombo B; di Poggio MLB; Favoni V; Grazzi L; Salerno A; Carnevale A; Robotti M; Frediani F; Altamura C; Filippi M; Vernieri F; Bonassi S;

Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study. in Neurology and therapy / Neurol Ther. 2024 Jun;13(3):611-624. doi: 10.1007/s40120-024-00591-z. Epub 2024 Mar 7.

2024
ASL Asti

Barbanti P; Egeo G; Proietti S; d'Onofrio F; Aurilia C; Finocchi C; Di Clemente L; Zucco M; Doretti A; Messina S; Autunno M; Ranieri A; Carnevale A; Colombo B; Filippi M; Tasillo M; Rinalduzzi S; Querzani P; Sette G; Forino L; Zoroddu F; Robotti M; Valenza A; Camarda C; Borrello L; Aguggia M; Viticchi G; Tomino C; Fiorentini G; et alii...

Correction to: Ultra-late response (>?24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study (Journal of Neurology, (2024), 271, 5, (2434-2443), 10.1007/s00415-023-12103-4) in Journal of Neurology

2024
ASL Asti

Barbanti P; Aurilia C; Egeo G; Proietti S; D’Onofrio F; Torelli P; Aguggia M; Bertuzzo D; Finocchi C; Trimboli M; Cevoli S; Fiorentini G; Orlando B; Zucco M; Di Clemente L; Cetta I; Colombo B; di Poggio MLB; Favoni V; Grazzi L; Salerno A; Carnevale A; Robotti M; Frediani F; Altamura C; Filippi M; Vernieri F; Bonassi S;

Correction to: Ultra-late response (>?24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study (Journal of Neurology, (2024), 271, 5, (2434-2443), 10.1007/s00415-023-12103-4) in Journal of Neurology

2024
ASL Asti

Barbanti P; Aurilia C; Egeo G; Proietti S; D’Onofrio F; Torelli P; Aguggia M; Bertuzzo D; Finocchi C; Trimboli M; Cevoli S; Fiorentini G; Orlando B; Zucco M; Di Clemente L; Cetta I; Colombo B; di Poggio MLB; Favoni V; Grazzi L; Salerno A; Carnevale A; Robotti M; Frediani F; Altamura C; Filippi M; Vernieri F; Bonassi S;

Correction to: Ultra-late response (>?24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study (Journal of Neurology, (2024), 271, 5, (2434-2443), 10.1007/s00415-023-12103-4) in Journal of Neurology

2024
ASL Asti

Barbanti P; Aurilia C; Egeo G; Proietti S; D’Onofrio F; Torelli P; Aguggia M; Bertuzzo D; Finocchi C; Trimboli M; Cevoli S; Fiorentini G; Orlando B; Zucco M; Di Clemente L; Cetta I; Colombo B; di Poggio MLB; Favoni V; Grazzi L; Salerno A; Carnevale A; Robotti M; Frediani F; Altamura C; Filippi M; Vernieri F; Bonassi S;

Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study. in The journal of headache and pain / J Headache Pain. 2023 Mar 23;24(1):30. doi: 10.1186/s10194-023-01561-w.

2023
ASL Asti

Barbanti P; Egeo G; Aurilia C; Torelli P; Finocchi C; d'Onofrio F; d'Onofrio L; Rao R; Messina S; Di Clemente L; Ranieri A; Autunno M; Sette G; Colombo B; Carnevale A; Aguggia M; Tasillo M; Zoroddu F; Frediani F; Filippi M; Tomino C; Proietti S; Bonassi S;

Late response to anti-CGRP (calcitonin gene-related peptide) monoclonal antibodies: implication for clinical practice in European Journal of Neurology

2022
ASL Asti

Aurilia C; Egeo G; Fiorentini G; Cevoli S; Messina R; Salerno A; Torelli P; Albanese M; Carnevale A; Bono F; D'Amico D; Altamura C; Colombo B; Frediani F; Mercuri B; D'Onofrio F; Grazzi L; Aguggia M; Finocchi C; Di Fiore P; Zucco M; Trimboli M; Bonassi S; Vernieri F; Barbanti P;

Late response to anti-CGRP monoclonal antibodies occurs in one-third of migraine patients in Headache

2022
ASL Asti

Aurilia C; Egeo G; Fiorentini G; Cevoli S; Messina R; Torelli P; Salerno A; Albanese M; Carnevale A; d'Onofrio F; Finocchi C; Altamura C; Aguggia M; Mercuri B; Bono F; Grazzi L; D'Amico D; Filippi M; Colombo B; Frediani F; Favoni V; Di Fiore P; Bertuzzo D; Zucco M; Di Clemente L; Trimboli M; Proietti S; Bonassi S; Vernieri F; et alii...

Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients in Journal of Headache and Pain

2022
ASL Asti

Barbanti P; Egeo G; Aurilia C; Altamura C; d’Onofrio F; Finocchi C; Albanese M; Aguggia M; Rao R; Zucco M; Frediani F; Filippi M; Messina R; Cevoli S; Carnevale A; Fiorentini G; Messina S; Bono F; Torelli P; Proietti S; Bonassi S; Vernieri F;

Long term (48-weeks) effectiveness, safety and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in real-world: The early 2 study in Journal of the Neurological Sciences

2021
ASL Asti

Aurilia C; Cevoli S; Egeo G; Fofi L; Messina R; Salerno A; Torelli P; Albanese M; Carnevale A; Bono F; D'Amico D; Filippi M; Altamura C; Vernieri F; Colombo B; Frediani F; Mercuri B; D'Onofrio F; Grazzi L; Aguggia M; Favoni V; Finocchi C; Di Fiore P; Costa CM; Brunelli N; Fallacara A; Bertuzzo D; Zucco M; Di Clemente L; et alii...

Long-term (>48 weeks) safety and tolerability of erenumab in real-life in Journal of the Neurological Sciences

2021
ASL Asti

Aurilia C; Egeo G; Fofi L; Cevoli S; Messina R; Salerno A; Torelli P; Albanese M; Carnevale A; Bono F; D'Amico D; Filippi M; Altamura C; Vernieri F; Colombo B; Frediani F; Mercuri B; D'Onofrio F; Grazzi L; Aguggia M; Favoni V; Finocchi C; Fiore PD; Costa CM; Brunelli N; Fallacara A; Bertuzzo D; Zucco M; Di Clemente L; et alii...

Long-term (>48 weeks) safety and tolerability of erenumab in reallife in Journal of Headache and Pain

2021
ASL Asti

Aurilia C; Cevoli S; Egeo G; Fofi L; Messina R; Salerno A; Torelli P; Albanese M; Carnevale A; Bono F; D'Amico D; Filippi M; Altamura C; Vernieri F; Colombo B; Frediani F; Mercuri B; D'Onofrio F; Grazzi L; Aguggia M; Favoni V; Finocchi C; Di Fiore P; Costa CM; Brunelli N; Fallacara A; Bertuzzo D; Zucco M; Di Clemente L; et alii...

New evidence from the italian chronic migraine registry (iron registry): An update on 866 patients in Neurology

2020
ASL Asti

Barbanti P; Fofi L; Egeo G; Aurilia C; Grazzi L; Vernieri F; Altamura C; Camarda C; Torelli P; Cevoli S; Russo A; Bono F; Finocchi C; Rao R; Messina S; De Simone R; D'Onofrio F; Aguggia M; Frediani F; Carnevale A; Autunno M; Lia C; Battista Allais G; Coppola A; Perini F; Balsamo P; Strumia S; Colombo B; Proietti S; et alii...